Sodium–Glucose Cotransporter 2 Inhibitors Inversed the Risk of Depre

Introduction

Type 2 diabetes mellitus (T2DM) is a complex chronic disease that requires continuous medical care and comprehensive risk-reduction strategies extending beyond glycemic management.1 T2DM is characterized by pancreatic β-cell…

Continue Reading